MX360848B - Método par abolizar polietilenglicol en una solución concentrada terapéutica. - Google Patents

Método par abolizar polietilenglicol en una solución concentrada terapéutica.

Info

Publication number
MX360848B
MX360848B MX2013004736A MX2013004736A MX360848B MX 360848 B MX360848 B MX 360848B MX 2013004736 A MX2013004736 A MX 2013004736A MX 2013004736 A MX2013004736 A MX 2013004736A MX 360848 B MX360848 B MX 360848B
Authority
MX
Mexico
Prior art keywords
solution concentrate
therapeutic solution
solution
poly
ethylene glycol
Prior art date
Application number
MX2013004736A
Other languages
English (en)
Other versions
MX2013004736A (es
Inventor
Kevin C Fowler
Joseph P Reo
Dennis Nelson
Mohammed A Kabir
Michael P Tune
Nanhye Kim
Anna W Tai
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of MX2013004736A publication Critical patent/MX2013004736A/es
Publication of MX360848B publication Critical patent/MX360848B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se provee una solución concentrada de poli(etilenglicol) que tiene buena estabilidad para el almacenamiento prolongado, para usarse como laxante; la solución concentrada comprende agua, benzoato de sodio, poli(etilenglicol), y suficiente ácido para dar una solución que tiene un pH a 25°C en la gama de 3.0-5.0; se prepara y se empaca para reducir al mínimo la acumulación de los productos de degradación.
MX2013004736A 2010-10-29 2011-10-24 Método par abolizar polietilenglicol en una solución concentrada terapéutica. MX360848B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40796910P 2010-10-29 2010-10-29
PCT/US2011/057494 WO2012058157A1 (en) 2010-10-29 2011-10-24 Therapeutic solution concentrate

Publications (2)

Publication Number Publication Date
MX2013004736A MX2013004736A (es) 2013-06-05
MX360848B true MX360848B (es) 2018-11-20

Family

ID=45994344

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004736A MX360848B (es) 2010-10-29 2011-10-24 Método par abolizar polietilenglicol en una solución concentrada terapéutica.

Country Status (8)

Country Link
US (2) US20120220654A1 (es)
EP (1) EP2632578A4 (es)
AU (1) AU2011320635B2 (es)
BR (1) BR112013010340A2 (es)
CA (1) CA2817068C (es)
MX (1) MX360848B (es)
RU (1) RU2576026C2 (es)
WO (1) WO2012058157A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937130A (en) * 1989-01-18 1990-06-26 General Electric Company Polycarbonate container having internal layers of amorphous polyamide
MX9303141A (es) * 1992-05-28 1994-04-29 Polar Materials Inc Metodos y aparatos para depositar recubrimientos de barrera.
KR100516550B1 (ko) * 1996-09-23 2005-09-22 비피 코포레이션 노쓰 아메리카 인코포레이티드 산소 투과 내성이 향상된 다층 열가소성의 식료품 보관용 용기 또는 병과 그 제조방법
CA2521420A1 (en) * 2003-04-08 2004-10-28 Progenics Pharmaceuticals, Inc. Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
DE10358213A1 (de) * 2003-12-12 2005-07-28 Clariant Gmbh Polyethylenglykol und dessen Herstellung
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US7423888B2 (en) * 2005-06-08 2008-09-09 Tamura Corporation Voltage conversion circuit and switching power supply device
CA2613818C (en) * 2005-06-30 2013-08-27 Centocor, Inc. Anti-il-23 antibodies, compositions, methods and uses

Also Published As

Publication number Publication date
WO2012058157A1 (en) 2012-05-03
RU2013124831A (ru) 2014-12-10
AU2011320635A1 (en) 2013-05-02
EP2632578A1 (en) 2013-09-04
MX2013004736A (es) 2013-06-05
RU2576026C2 (ru) 2016-02-27
AU2011320635B2 (en) 2016-02-04
US20140080918A1 (en) 2014-03-20
US20120220654A1 (en) 2012-08-30
EP2632578A4 (en) 2014-12-03
CA2817068A1 (en) 2012-05-03
BR112013010340A2 (pt) 2016-08-02
CA2817068C (en) 2020-04-21

Similar Documents

Publication Publication Date Title
MY156938A (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
MY161243A (en) Fluorinated aminotriazole derivatives
NZ626618A (en) Hydroxamic acid derivatives and uses thereof
MY183312A (en) Pharmaceutical formulation
MX2019003693A (es) Formulaciones de insulina de accion prolongada.
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2012009523A3 (en) A personal care composition comprising a near-terminal branched compound
NZ603155A (en) Phospholipid drug analogs
MY165624A (en) N-acylsulfonamide apoptosis promoters
WO2014040052A3 (en) Glycyrrhetinic acid derivatives with anti-inflammatory activity
MX2012012941A (es) Nuevas composiciones oftalmicas.
WO2012071149A3 (en) Branched secondary alcohol alkoxylate surfactants and process to make them
NZ601043A (en) Nutritive compositions and methods of using same
IN2012DN00765A (es)
WO2013116753A8 (en) Fatty acids as anti-inflammatory agents
JO3229B1 (ar) العمل على استقرار الهرمون المنبه للجريب
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
AR091644A1 (es) Composicion alimenticia concentrada en forma de gel
MX2013002620A (es) Novedosas n-hidroxi-benzamidas para el tratamiento del cancer.
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
WO2012080978A3 (en) Cold weather compatible crosslinker solution
MX2012010935A (es) Formulacion acuosa estable mejorada de (e)-4-carboxiestiril-4-clor obencil sulfona.
HK1188983A1 (en) Novel dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient
MX2010003594A (es) Formas cristalinas de sal sodica de dmxaa.
MX360848B (es) Método par abolizar polietilenglicol en una solución concentrada terapéutica.

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: BAYER CONSUMER CARE AG

GB Transfer or rights

Owner name: BAYER CONSUMER CARE AG

FG Grant or registration